ARCA biopharma, Inc. Bonus & Incentive Agreements
29 Contracts & Agreements
- Second Amendment to Amended and Restated Oruka Therapeutics, Inc. 2024 Equity Incentive Plan, effective as of May 7, 2024 (Filed With SEC on September 5, 2024)
- Oruka Therapeutics, Inc. 2024 Stock Incentive Plan (Filed With SEC on September 5, 2024)
- Form of Stock Option Agreement under Oruka Therapeutics, Inc. 2024 Equity Incentive Plan (Filed With SEC on May 14, 2024)
- Amended and Restated Oruka Therapeutics, Inc. 2024 Equity Incentive Plan, as amended by the First Amendment dated May 7, 2024 (Filed With SEC on May 14, 2024)
- Second Amendment to Retention Bonus Letter, dated April 22, 2024, by and between ARCA biopharma, Inc. and C. Jeffrey Dekker (Filed With SEC on April 23, 2024)
- Second Amendment to Retention Bonus Letter, dated April 22, 2024, by and between ARCA biopharma, Inc. and Thomas A. Keuer (Filed With SEC on April 23, 2024)
- Amendment to Retention Bonus Letter, dated December 4, 2023, by and among ARCA biopharma, Inc. and C. Jeffrey Dekker (Filed With SEC on December 4, 2023)
- Amendment to Retention Bonus Letter, dated December 4, 2023, by and among ARCA biopharma, Inc. and Thomas A. Keuer (Filed With SEC on December 4, 2023)
- Memorandum Regarding Cash Retention Bonus between ARCA biopharma, Inc. and C. Jeffrey Dekker dated December 8, 2022 (Filed With SEC on December 9, 2022)
- Memorandum Regarding Cash Retention Bonus between ARCA biopharma, Inc. and Thomas A. Keuer dated December 8, 2022 (Filed With SEC on December 9, 2022)
- Form of Restricted Stock Unit Award Agreement and Notice of Grant Award under 2020 Equity Incentive Plan (Officer) (Filed With SEC on December 23, 2020)
- Form of Restricted Stock Unit Award Agreement and Notice of Grant Award under 2020 Equity Incentive Plan (Standard) (Filed With SEC on December 23, 2020)
- Form of Stock Option Agreement and Option Grant Notice under 2020 Equity Incentive Plan (Director) (Filed With SEC on December 23, 2020)
- Form of Stock Option Agreement and Option Grant Notice under 2020 Equity Incentive Plan (Officer) (Filed With SEC on December 23, 2020)
- Form of Stock Option Agreement and Option Grant Notice under 2020 Equity Incentive Plan (Standard) (Filed With SEC on December 23, 2020)
- ARCA biopharma, Inc. 2020 Equity Incentive Plan (Filed With SEC on December 10, 2020)
- ARCA BIOPHARMA, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on September 23, 2013)
- ARCA BIOPHARMA, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on September 23, 2013)
- ARCA BIOPHARMA, INC. STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on September 23, 2013)
- ARCA BIOPHARMA, INC. STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on September 23, 2013)
- ARCA BIOPHARMA, INC. STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on September 23, 2013)
- ARCA BIOPHARMA, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JULY 26, 2013 APPROVED BY THE STOCKHOLDERS:SEPTEMBER 17, 2013 EFFECTIVE DATE: SEPTEMBER 17, 2013 (Filed With SEC on September 23, 2013)
- ARCA DISCOVERY, INC. 2004 STOCK INCENTIVE PLAN (Filed With SEC on January 28, 2009)
- ARCA BIOPHARMA, INC. 2004 STOCK INCENTIVE PLAN (Filed With SEC on January 28, 2009)
- ARCADISCOVERY, INC. 2004 STOCK INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on January 28, 2009)
- ARCA DISCOVERY, INC. 2004 STOCK INCENTIVE PLAN TABLE OF CONTENTS (Filed With SEC on January 28, 2009)
- NUVELO, INC. 2004 EQUITY INCENTIVE PLAN TABLE OF CONTENTS (Filed With SEC on August 8, 2006)
- Nuvelo, Inc. Management Bonus Amounts for Named Executive Officers for the 2005 Fiscal Year (Filed With SEC on February 10, 2006)
- 2004 EQUITY INCENTIVE PLAN TABLE OF CONTENTS (Filed With SEC on August 8, 2005)
